Inactive Instrument

Calendar Mylan N.V. Nasdaq

Equities

MYL

NL0011031208

Chart calendar Mylan N.V.

1cb01a1aade80a510b7.MpMob6MHF5TyKGjj6ChSdb8cir1oYvlRukSAmZA7rkY.C8B6FvtCfeWhahGZ21kFBPNOwdE6LL8c-DfQ7Mh34C9Wwxk3jkt958cfBw~a6a9b3f9ab4cf61fcb77f068476292c1

Upcoming events on Mylan N.V.

08/05/2024 Q1 2024 Earnings Release Pre-market
09/05/2024 13:30 Q1 2024 Earnings Call
04/08/2024 Q2 2024 Earnings Release (Projected)
03/11/2024 Q3 2024 Earnings Release (Projected)
02/03/2025 Q4 2024 Earnings Release (Projected)
11/05/2025 Q1 2025 Earnings Release (Projected)

Past events on Mylan N.V.

27/03/2024 14:00 R&D Day
07/03/2024 Ex-dividend day
28/02/2024 13:30 Q4 2023 Earnings Call
28/02/2024 11:30 Q4 2023 Earnings Release
10/01/2024 18:30 JPMorgan Healthcare Conference
15/12/2023 16:00 Annual General Meeting
21/11/2023 Ex-dividend day
15/11/2023 09:30 Jefferies London Healthcare Conference
07/11/2023 22:00 Q3 2023 Earnings Call
07/11/2023 21:02 Q3 2023 Earnings Release
22/08/2023 Ex-dividend day
07/08/2023 13:30 Q2 2023 Earnings Call
07/08/2023 11:59 Q2 2023 Earnings Release
13/06/2023 21:20 Goldman Sachs Global Healthcare Conference
22/05/2023 Ex-dividend day
08/05/2023 13:30 Q1 2023 Earnings Call
08/05/2023 11:59 Q1 2023 Earnings Release
24/04/2023 22:30 American Academy of Neurology Meeting - Poster #014
07/03/2023 Ex-dividend day
27/02/2023 13:30 Q4 2022 Earnings Call

Annual results

Fiscal PeriodDecember 2019 2020 2021 2022 2023 2024
Net sales
Million USD
Released
Forecast
Spread
11 501
11 537
-0.32%
11 946
12 273
-2.66%
17 886
17 881
0.03%
16 263
16 372
-0.67%
15 427
15 465
-0.25%

15 219

EBITDA
Million USD
Released
Forecast
Spread
3 540
3 500
1.12%
3 654
4 483
-18.49%
6 426
6 464
-0.59%
5 777
5 852
-1.29%
5 124
5 197
-1.4%

4 885

EBIT
Million USD
Released
Forecast
Spread
3 264
3 212
1.62%
3 376
3 864
-12.61%
6 046
6 111
-1.07%
5 475
5 566
-1.62%
4 725
4 851
-2.6%

4 570

Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
154
807
-80.87%
-721
3 677
-119.61%
-664
-580
-14.55%
2 813
878
220.41%
203
1 198
-83.06%

4 100

Net income
Million USD
Released
Forecast
Spread
16,8
427
-96.07%
-670
1 449
-146.24%
-1 269
-952
-33.29%
2 079
1 328
56.46%
54,7
812
-93.26%

1 885

EPS
USD
Released
Forecast
Spread
0,03
0,81
-96.3%
-1,11
1,62
-168.59%
-1,05
-0,77
-36.36%
1,71
1,01
69.62%
0,05
0,84
-94.02%

1,45

Announcement Date27/02/2001/03/2128/02/2227/02/2328/02/24-

Quarterly results

Fiscal PeriodDecember 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1
Net sales
Million USD
Released
Forecast
Spread
4 342
4 337
0.11%
4 192
4 258
-1.55%
4 117
4 185
-1.62%
4 078
4 136
-1.39%
3 876
3 988
-2.8%
3 729
3 812
-2.18%
3 919
3 862
1.45%
3 942
3 997
-1.37%
3 837
3 877
-1.03%

3 707


3 830


3 908


3 896


3 821

EBITDA
Million USD
Released
Forecast
Spread
1 416
1 481
-4.39%
1 586
1 445
9.8%
1 482
1 443
2.73%
1 498
1 431
4.69%
1 211
1 288
-6%
1 341
1 222
9.69%
1 306
1 255
4.04%
1 360
1 293
5.2%
1 117
1 220
-8.44%

1 247


1 188


1 258


1 195




EBIT
Million USD
Released
Forecast
Spread
1 314
1 383
-5.04%
1 551
1 375
12.82%
1 425
1 375
3.57%
1 415
1 368
3.4%
1 085
1 166
-6.96%
1 255
1 151
9.02%
1 226
1 178
4.12%
1 257
1 208
4.05%
987
1 100
-10.29%

1 101


1 139


1 191


1 125


1 131

Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
-204
-119
-71.34%
528
48,0
998.96%















402
260
54.69%
-855
140
-710.71%















Net income
Million USD
Released
Forecast
Spread
-264
53,2
-595.86%
399
149
167.56%
314
234
34.21%
354
357
-0.78%
1 011
257
292.86%
225
154
46.31%
264
225
17.13%
332
246
35.03%
-766
114
-771.58%

123


144


188


188




EPS
USD
Released
Forecast
Spread
-0,22
0,41
-154.32%
0,33
0,08
304.11%
0,26
0,19
36.43%
0,29
0,42
-31.07%
0,83
0,15
453%
0,19
0,23
-15.82%
0,22
0,20
8.2%
0,27
0,34
-20.08%
-0,64
0,26
-344.8%

0,12


0,14


0,23


0,30




Announcement Date28/02/2209/05/2208/08/2207/11/2227/02/2308/05/2307/08/2307/11/2328/02/24-----